cmybp c (Santa Cruz Biotechnology)
93
Structured Review
Santa Cruz Biotechnology
cmybp c
Cmybp C, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 96 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cmybp+c/MYBPC3+Antibody/bio_rxiv__2025__09__29__679322-61-13-14
Average 93 stars, based on 96 article reviews
Cmybp C, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 96 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cmybp+c/MYBPC3+Antibody/bio_rxiv__2025__09__29__679322-61-13-14
Average 93 stars, based on 96 article reviews
cmybp c - by Bioz Stars,
2026-11
93/100 stars
Images
Related Articles
Incubation:Article Title: The selective serotonin reuptake inhibitor paroxetine improves right ventricular systolic function in experimental pulmonary hypertension Article Snippet: Membranes were then washed in 1 × TBST and blocked for 1 h at room temperature in blocking solution (Blocking One, Nacalai Tesque, Kyoto, Japan). .. After washing in 1 × TBST, membranes were incubated in primary antibody at 4 ◦C overnight against the following proteins: GRK2 (1:2000; Novus Biologicals, NBP2–37611), β1AR (1:100, Santa Cruz Biotechnology, sc568), tyrosine hydroxylase (1:1000; GeneTex, GTX113016), Article Title: Missense variants in the myosin binding domains of MYBPC3 and MYBPHL impair sarcomere incorporation Article Snippet: .. Primary antibodies against MyBP-HL (Barefield et al., 2022; 1:2,500), Anti-DDK (Origene, TA150078) and Article Title: MYBPHL nonsense mutations have poor sarcomere binding, are degraded, and cause abnormal contraction Article Snippet: .. Primary antibodies against MyBP-HL (Barefield, 2022; 1:2500, ( )) and Article Title: The selective serotonin reuptake inhibitor paroxetine improves right ventricular systolic function in experimental pulmonary hypertension Article Snippet: Membranes were then washed in 1 × TBST and blocked for 1 h at room temperature in blocking solution (Blocking One, Nacalai Tesque, Kyoto, Japan). .. After washing in 1 × TBST, membranes were incubated in primary antibody at 4 °C overnight against the following proteins: GRK2 (1:2000; Novus Biologicals, NBP2–37611), β 1 AR (1:100, Santa Cruz Biotechnology, sc-568), tyrosine hydroxylase (1:1000; GeneTex, GTX113016), other:Article Title: Gestational arsenite exposure alters maternal postpartum heart size and induces Ca 2+ -handling dysregulation in cardiomyocytes Article Snippet: Membranes were blocked (1h) with bovine serum albumin (5% wt/vol, Sigma-Aldrich) in Tris-buffered saline with Tween-20 (0.1%), and subsequently incubated (overnight, 4 °C) with primary antibodies for p-Akt (S473) (1:1000, Rabbit mAb, Cell Signaling, 4060S), Akt (pan) (1:1000, Rabbit mAb, Cell Signaling, 4691S), p-eNOS (S1177) (1:1000, Rabbit mAb, Cell Signaling, 9571S), eNOS (1:500, Rabbit mAb, Santa Cruz, sc-376751), p-p44/42 MAPK (T202/Y204) (1:1000, Rabbit Ab, Cell Signaling, 9101S), p44/42 MAPK (ERK1/2) (1:1000, Rabbit mAb, Cell Signaling, 9102S), SERCA2a (1:500, Goat Ab, Blocking Assay:Article Title: Missense variants in the myosin binding domains of MYBPC3 and MYBPHL impair sarcomere incorporation Article Snippet: .. Primary antibodies against MyBP-HL (Barefield et al., 2022; 1:2,500), Anti-DDK (Origene, TA150078) and Article Title: MYBPHL nonsense mutations have poor sarcomere binding, are degraded, and cause abnormal contraction Article Snippet: .. Primary antibodies against MyBP-HL (Barefield, 2022; 1:2500, ( )) and |